Retinal prostheses are designed to help people with vision loss from conditions like macular degeneration and retinitis pigmentosa. Traditional methods, like implanted electrodes or gene-based treatment, can be invasive and have limits in how clearly or widely they restore vision.
Newer techniques using nanoparticles are less invasive, but some need bright visible light, which can harm any remaining vision. A promising alternative uses tiny gold rods (called plasmonic gold nanorods) that respond to near-infrared (NIR) light, which is gentler on the eyes. These rods can heat up and stimulate nerve cells without damaging existing sight.
However, using this method with precise laser patterns to control nerve activity is still a new and largely unexplored area.
In a groundbreaking study, researchers at Brown University have developed a new type of visual prosthesis that could help restore sight without surgery or genetic tweaks.
Scientists Have Created an Artificial Retinal Implant That Could Restore Vision to Millions
The approach is surprisingly simple: inject gold nanoparticles into the retina. These tiny particles can stimulate the visual system, potentially bringing back vision lost due to conditions like macular degeneration and other retinal diseases.
Unlike traditional treatments that require implants or gene therapy, this method is minimally invasive and avoids complex procedures. While more research is needed, scientists believe this could one day offer a safe, effective way to help millions regain their sight with just a tiny golden boost.
Jiarui Nie, a postdoctoral researcher at the National Institutes of Health who led the research while completing her Ph.D. at Brown, said, “We believe this technique could potentially transform treatment paradigms for retinal degenerative conditions.”
Here’s how it works: in diseases like macular degeneration, the eye’s light-sensing cells (photoreceptors) are damaged, but deeper cells like bipolar and ganglion cells remain intact. The new technique injects gold nanoparticles directly into the retina, where they settle near these healthy cells.
When near-infrared light is shone onto the retina, the nanoparticles gently heat up and activate the bipolar and ganglion cells, mimicking the natural signals photoreceptors would send. This effectively reroutes the visual signal, allowing the brain to receive images again.
In tests on mice with retinal disorders, researchers projected laser patterns onto the retina. The nanoparticles responded by activating the correct cells in matching patterns, proving the system works.
Imagine restoring sight not with surgery or implants, but with a simple injection and a pair of smart goggles. That’s the future scientists at Brown University are working toward, thanks to a groundbreaking new study using gold nanoparticles to bring back vision lost to retinal diseases.
In mouse experiments, researchers injected a solution of gold nanoparticles into the retina. When near-infrared laser light was projected onto the eye, the nanoparticles gently heated up and activated bipolar and ganglion cells, the deeper layers of the retina that remain intact in conditions like macular degeneration.
Exploring the human retina: A detailed look
The results were remarkable: not only did the nanoparticles trigger activity in the retina, but brain scans also showed increased activity in the visual cortex, a clear sign that visual signals were reaching the brain. Even better, there were no signs of inflammation or toxicity, making the method both effective and safe in early tests.
The team envisions a wearable system for humans: goggles equipped with cameras and an infrared laser. The cameras would capture the world in real-time, and the laser would project those images onto the retina, activating the nanoparticles and allowing the user to see.
Compared to older systems, like the FDA-approved retinal implants that use electrode arrays, this new method has major advantages:
- Minimally invasive: No surgery is needed, just a simple eye injection.
- Higher resolution: Unlike fixed electrode grids, the nanoparticles spread across the entire retina, potentially restoring a full field of vision.
- Preserve remaining sight: Because it uses infrared light, it won’t interfere with any vision the person still has.
While more research is needed before human trials begin, the early results are promising. As lead researcher Nie put it, “We showed that the nanoparticles can stay in the retina for months with no major toxicity. And we showed that they can successfully stimulate the visual system. That’s very encouraging for future applications.”
Journal Reference:
- Jiarui Nie, Kyungsik Eom, Hafithe M. AlGhosain, et al. Intravitreally Injected Plasmonic Nanorods Activate Bipolar Cells with Patterned Near-Infrared Laser Projection. ACS Nano. DOI: 10.1021/acsnano.4c14061
